UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045048
Receipt number R000051447
Scientific Title Survey for nurses'burden feeling to defecation management for dementia patients with chronic constipation before and after elobixibat introduction
Date of disclosure of the study information 2021/08/06
Last modified on 2022/04/11 11:23:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Survey for nurses'burden feeling to defecation management for dementia patients with chronic constipation before and after elobixibat introduction

Acronym

Survey for nurses'burden feeling to defecation management for dementia patients with chronic constipation before and after elobixibat introduction

Scientific Title

Survey for nurses'burden feeling to defecation management for dementia patients with chronic constipation before and after elobixibat introduction

Scientific Title:Acronym

Survey for nurses'burden feeling to defecation management for dementia patients with chronic constipation before and after elobixibat introduction

Region

Japan


Condition

Condition

Dementia patients with chronic constipation

Classification by specialty

Hepato-biliary-pancreatic medicine Psychiatry Nursing

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

In this study, we research how the nurses' burden feelings to defecation management for dementia patients with chronic constipation changes by using eroxibat

Basic objectives2

Others

Basic objectives -Others

Nursing Research

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Changes of nurses' burden feeling to defection management before and after elobixibat introduction each for patients who go to the restroom by themselves and bedridden patents

Key secondary outcomes

Evaluations for each questions in the questionnaire.
The prescription situation of the enema in fifth ward.


Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Nurses who have worked in the fifth ward as the ward for dementia patients on September 2019.
Nurses who agreed that one can answer the questionnaire.

Key exclusion criteria

Nurses who have no experience to defection management of patients using elobixibat.
Nurses who have no experience to defection management of constipation patients before elobixibat introduction.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Mayumi
Middle name
Last name Fukuhara

Organization

MATSUGAOKA HOSPITAL

Division name

Nursing Dept.

Zip code

698-0041

Address

4-24-10 Takatsu Masuda City,Shimane

TEL

0856-22-8730

Email

matugaoka@matugaoka-iatria.jp


Public contact

Name of contact person

1st name Minami
Middle name
Last name Umeyama

Organization

EA Pharma Co.,Ltd.

Division name

Medical Dept.

Zip code

104-0042

Address

2-1-1 Irifune Chuo-ku,Tokyo

TEL

03-6280-9814

Homepage URL


Email

minami_umeyama@eapharma.co.jp


Sponsor or person

Institute

EA Pharma Co.,Ltd.

Institute

Department

Personal name



Funding Source

Organization

EA Pharma Co.,Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Yamauchi Clinic IRB

Address

1-15-19, Jiyugaoka, Meguro Ku, Tokyo To, Japan

Tel

03-6777-1490

Email

c-irb_ug@neues.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 08 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

17

Results

The burden of nurses decreased to 62.9% in "patients who can go to the toilet by themselves" and to 73.8% in "bedridden patients" after the introduction of elobixibat, indicating a significant decrease in the burden of nurses in both groups (p<0.001).
The main reason for the change in burden was a decrease in the frequency of enemas.

Results date posted

2022 Year 04 Month 11 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

The mean and median nursing experience was 18.4 and 15.0 years, respectively, and the majority of the nurses were skilled nurses with a great deal of clinical experience. The 7.7 hours of nursing work per day were spent on average. Of the average 14.4 patients with chronic constipation for whom nurses were responsible, 7.6 patients were able to go to the toilet on their own and 6.7 patients were bedridden.

Participant flow


Adverse events


Outcome measures

(1)Changes in time of defecation management After the introduction of elobixibat, the number of patients who could go to the toilet by themselves decreased by 7.7 minutes, a significant decrease (p<0.001), while the number of patients who were bedridden decreased by 7.5 minutes, but the difference was not significant.
(2)Results of the number of enemas performed in dementia treatment wards The number of enemas per nurse decreased from 5.5/month before the introduction of Elobixibat to 3.9/month after the introduction (p<0.001) during the January-August period.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2021 Year 05 Month 31 Day

Date of IRB

2021 Year 08 Month 10 Day

Anticipated trial start date

2021 Year 08 Month 10 Day

Last follow-up date

2021 Year 08 Month 31 Day

Date of closure to data entry

2021 Year 09 Month 16 Day

Date trial data considered complete

2021 Year 09 Month 16 Day

Date analysis concluded

2021 Year 11 Month 30 Day


Other

Other related information

None


Management information

Registered date

2021 Year 08 Month 03 Day

Last modified on

2022 Year 04 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051447


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name